Gene Symbol | Gene ID | Gene Info |
---|---|---|
DLX4
|
ENSG00000108813.9 | distal-less homeobox 4 |
HOXD8
|
ENSG00000175879.7 | homeobox D8 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_48045399_48045550 | DLX4 | 1064 | 0.411998 | 0.70 | 3.6e-02 | Click! |
chr17_48047524_48047675 | DLX4 | 905 | 0.509731 | 0.64 | 6.4e-02 | Click! |
chr17_48055702_48055853 | DLX4 | 5647 | 0.158899 | -0.59 | 9.3e-02 | Click! |
chr17_48049156_48049307 | DLX4 | 899 | 0.516801 | -0.52 | 1.6e-01 | Click! |
chr17_48049549_48049847 | DLX4 | 432 | 0.789868 | 0.48 | 1.9e-01 | Click! |
chr2_176996786_176997434 | HOXD8 | 2025 | 0.132140 | 0.56 | 1.2e-01 | Click! |
chr2_176994944_176995095 | HOXD8 | 34 | 0.933636 | 0.54 | 1.4e-01 | Click! |
chr2_176993329_176993480 | HOXD8 | 1018 | 0.278914 | -0.51 | 1.6e-01 | Click! |
chr2_176995444_176995790 | HOXD8 | 532 | 0.536075 | 0.49 | 1.8e-01 | Click! |
chr2_176992049_176992222 | HOXD8 | 2287 | 0.120042 | 0.38 | 3.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_121320555_121321108 | 1.70 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
2081 |
0.35 |
chr14_99726122_99726406 | 1.55 |
AL109767.1 |
|
3021 |
0.29 |
chr2_106375349_106375537 | 1.53 |
NCK2 |
NCK adaptor protein 2 |
13255 |
0.28 |
chr3_59997046_59997753 | 1.41 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
39816 |
0.23 |
chr12_413278_413648 | 1.28 |
RP11-283I3.6 |
|
27174 |
0.14 |
chr8_82015786_82015967 | 1.20 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
8427 |
0.3 |
chr2_114633518_114633816 | 1.19 |
ACTR3 |
ARP3 actin-related protein 3 homolog (yeast) |
13870 |
0.21 |
chr2_26018726_26019025 | 1.18 |
ASXL2 |
additional sex combs like 2 (Drosophila) |
15697 |
0.23 |
chr1_29291606_29291930 | 1.18 |
ENSG00000206704 |
. |
20454 |
0.19 |
chrY_1731945_1732112 | 1.14 |
ENSG00000251841 |
. |
920762 |
0.0 |
chrX_1781946_1782112 | 1.14 |
ASMT |
acetylserotonin O-methyltransferase |
26738 |
0.22 |
chr1_172670656_172670827 | 1.14 |
FASLG |
Fas ligand (TNF superfamily, member 6) |
42583 |
0.18 |
chr12_66788011_66788363 | 1.11 |
ENSG00000238528 |
. |
48688 |
0.15 |
chr2_235395214_235395372 | 1.09 |
ARL4C |
ADP-ribosylation factor-like 4C |
9951 |
0.32 |
chr17_37970513_37970744 | 1.07 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
36150 |
0.11 |
chr12_92796420_92796828 | 1.06 |
RP11-693J15.4 |
|
18683 |
0.18 |
chr12_46611375_46611659 | 1.03 |
SLC38A1 |
solute carrier family 38, member 1 |
49967 |
0.18 |
chr2_143943022_143943284 | 1.03 |
RP11-190J23.1 |
|
13412 |
0.27 |
chr7_139856684_139856920 | 1.03 |
KDM7A |
lysine (K)-specific demethylase 7A |
19939 |
0.16 |
chr20_1639703_1639854 | 1.03 |
SIRPG |
signal-regulatory protein gamma |
1353 |
0.36 |
chr5_98363313_98363584 | 1.02 |
ENSG00000200351 |
. |
90997 |
0.09 |
chr6_128116786_128116937 | 1.02 |
THEMIS |
thymocyte selection associated |
105242 |
0.08 |
chr21_43843966_43844673 | 1.02 |
ENSG00000252619 |
. |
6617 |
0.14 |
chr14_52331770_52332050 | 1.02 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
3868 |
0.25 |
chr1_66803904_66804310 | 1.01 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
6235 |
0.32 |
chr14_61800103_61800254 | 0.99 |
PRKCH |
protein kinase C, eta |
6547 |
0.21 |
chr1_101746005_101746240 | 0.99 |
RP4-575N6.5 |
|
37408 |
0.14 |
chr2_169961679_169961830 | 0.99 |
AC007556.3 |
|
4501 |
0.26 |
chr3_107694284_107694711 | 0.99 |
CD47 |
CD47 molecule |
82711 |
0.11 |
chr6_154561193_154561344 | 0.98 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
6722 |
0.33 |
chrX_13773144_13773358 | 0.98 |
OFD1 |
oral-facial-digital syndrome 1 |
20387 |
0.16 |
chr2_205942725_205942950 | 0.97 |
PARD3B |
par-3 family cell polarity regulator beta |
532114 |
0.0 |
chr19_9419086_9419237 | 0.97 |
ZNF699 |
zinc finger protein 699 |
1088 |
0.37 |
chr18_68330921_68331227 | 0.97 |
GTSCR1 |
Gilles de la Tourette syndrome chromosome region, candidate 1 |
13094 |
0.31 |
chr9_33841783_33842038 | 0.97 |
ENSG00000200834 |
. |
10934 |
0.12 |
chrX_11784442_11784722 | 0.97 |
MSL3 |
male-specific lethal 3 homolog (Drosophila) |
6835 |
0.32 |
chr6_130898741_130899072 | 0.95 |
ENSG00000202438 |
. |
3649 |
0.36 |
chr3_71387446_71387597 | 0.94 |
FOXP1 |
forkhead box P1 |
33610 |
0.2 |
chr7_138731189_138731354 | 0.94 |
ZC3HAV1L |
zinc finger CCCH-type, antiviral 1-like |
10496 |
0.21 |
chr2_99279276_99279650 | 0.94 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
473 |
0.84 |
chr17_1775725_1776037 | 0.94 |
RPA1 |
replication protein A1, 70kDa |
6448 |
0.16 |
chr11_67170134_67170292 | 0.93 |
PPP1CA |
protein phosphatase 1, catalytic subunit, alpha isozyme |
811 |
0.3 |
chr21_19172929_19173211 | 0.93 |
AL109761.5 |
|
7265 |
0.23 |
chr1_226891897_226892201 | 0.92 |
ITPKB-IT1 |
ITPKB intronic transcript 1 (non-protein coding) |
29281 |
0.16 |
chr17_47825562_47826034 | 0.92 |
FAM117A |
family with sequence similarity 117, member A |
15695 |
0.14 |
chr3_107697281_107697722 | 0.92 |
CD47 |
CD47 molecule |
79707 |
0.11 |
chr6_41048012_41048396 | 0.91 |
NFYA |
nuclear transcription factor Y, alpha |
7482 |
0.13 |
chr11_128173540_128173801 | 0.91 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
201619 |
0.03 |
chr4_90218630_90219104 | 0.90 |
GPRIN3 |
GPRIN family member 3 |
10294 |
0.3 |
chr10_22899839_22899998 | 0.90 |
PIP4K2A |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
19276 |
0.27 |
chr1_229168669_229168958 | 0.90 |
RP5-1061H20.5 |
|
194496 |
0.02 |
chr6_112069279_112069430 | 0.90 |
FYN |
FYN oncogene related to SRC, FGR, YES |
10963 |
0.26 |
chr15_101112044_101112245 | 0.90 |
ENSG00000200095 |
. |
11147 |
0.13 |
chr1_111212434_111212585 | 0.90 |
KCNA3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
5146 |
0.2 |
chr3_114044957_114045108 | 0.89 |
ENSG00000207770 |
. |
9616 |
0.18 |
chr19_9976591_9976870 | 0.89 |
OLFM2 |
olfactomedin 2 |
7886 |
0.11 |
chr10_8130727_8131157 | 0.89 |
GATA3 |
GATA binding protein 3 |
34173 |
0.24 |
chr1_93445938_93446179 | 0.89 |
ENSG00000238787 |
. |
1807 |
0.23 |
chr2_143918611_143918880 | 0.89 |
RP11-190J23.1 |
|
10996 |
0.25 |
chr5_96140004_96140328 | 0.89 |
CTD-2260A17.3 |
|
110 |
0.95 |
chr7_37384431_37384846 | 0.88 |
ELMO1 |
engulfment and cell motility 1 |
1855 |
0.37 |
chr4_83296195_83296416 | 0.88 |
HNRNPD |
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) |
649 |
0.47 |
chr1_100887820_100887971 | 0.88 |
ENSG00000216067 |
. |
43564 |
0.14 |
chr7_150381782_150381933 | 0.88 |
GIMAP2 |
GTPase, IMAP family member 2 |
931 |
0.55 |
chr2_68431835_68432165 | 0.88 |
RP11-474G23.2 |
|
25035 |
0.12 |
chr4_39030463_39030661 | 0.87 |
TMEM156 |
transmembrane protein 156 |
3479 |
0.26 |
chr4_84134465_84134616 | 0.87 |
COQ2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
71378 |
0.1 |
chr13_108994464_108994711 | 0.87 |
ENSG00000223177 |
. |
40908 |
0.18 |
chr9_73011069_73011220 | 0.86 |
KLF9 |
Kruppel-like factor 9 |
18396 |
0.24 |
chr5_100161389_100161608 | 0.86 |
ENSG00000221263 |
. |
9229 |
0.28 |
chr7_138795801_138796188 | 0.86 |
ZC3HAV1 |
zinc finger CCCH-type, antiviral 1 |
1529 |
0.43 |
chr2_171508638_171509172 | 0.85 |
AC007277.3 |
|
8451 |
0.23 |
chr16_17546246_17546397 | 0.85 |
XYLT1 |
xylosyltransferase I |
18417 |
0.3 |
chr3_45912149_45912327 | 0.85 |
CCR9 |
chemokine (C-C motif) receptor 9 |
15758 |
0.16 |
chr3_56924360_56924511 | 0.85 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
26064 |
0.21 |
chrX_78355161_78355312 | 0.85 |
GPR174 |
G protein-coupled receptor 174 |
71233 |
0.13 |
chr8_66913743_66914032 | 0.84 |
DNAJC5B |
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
19908 |
0.26 |
chr5_78556716_78556867 | 0.84 |
JMY |
junction mediating and regulatory protein, p53 cofactor |
24779 |
0.17 |
chr12_10282940_10283100 | 0.84 |
CLEC7A |
C-type lectin domain family 7, member A |
164 |
0.93 |
chr8_121714189_121714356 | 0.84 |
RP11-713M15.1 |
|
59221 |
0.14 |
chr18_77195690_77195983 | 0.84 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
35444 |
0.19 |
chr4_78773591_78774044 | 0.84 |
MRPL1 |
mitochondrial ribosomal protein L1 |
9857 |
0.26 |
chr14_22520033_22520237 | 0.84 |
ENSG00000238634 |
. |
90752 |
0.09 |
chr6_144677205_144677534 | 0.83 |
UTRN |
utrophin |
12132 |
0.24 |
chr12_110905518_110905672 | 0.83 |
GPN3 |
GPN-loop GTPase 3 |
474 |
0.49 |
chr5_156681128_156681568 | 0.83 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
11743 |
0.13 |
chr3_107801472_107801678 | 0.83 |
CD47 |
CD47 molecule |
8286 |
0.31 |
chr5_39185202_39185385 | 0.83 |
FYB |
FYN binding protein |
17836 |
0.25 |
chr6_37878002_37878153 | 0.83 |
ENSG00000200597 |
. |
5272 |
0.24 |
chr7_138781025_138781365 | 0.83 |
ZC3HAV1 |
zinc finger CCCH-type, antiviral 1 |
12905 |
0.2 |
chr2_205745514_205745665 | 0.83 |
PARD3B |
par-3 family cell polarity regulator beta |
334866 |
0.01 |
chrX_149578349_149578500 | 0.82 |
MAMLD1 |
mastermind-like domain containing 1 |
10849 |
0.27 |
chr11_104826960_104827245 | 0.82 |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
323 |
0.9 |
chr9_117701644_117701992 | 0.82 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
9121 |
0.28 |
chr19_50005184_50005425 | 0.82 |
ENSG00000207782 |
. |
1179 |
0.17 |
chr1_10562561_10562712 | 0.82 |
PEX14 |
peroxisomal biogenesis factor 14 |
27597 |
0.11 |
chr4_71976630_71976836 | 0.82 |
SLC4A4 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
76270 |
0.11 |
chr2_62435329_62435921 | 0.82 |
ENSG00000266097 |
. |
2664 |
0.25 |
chr3_151918042_151918282 | 0.82 |
MBNL1 |
muscleblind-like splicing regulator 1 |
67667 |
0.12 |
chr9_21983229_21983380 | 0.82 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
8207 |
0.14 |
chr19_14461542_14461693 | 0.81 |
CD97 |
CD97 molecule |
30351 |
0.13 |
chr12_9104675_9104919 | 0.81 |
KLRG1 |
killer cell lectin-like receptor subfamily G, member 1 |
2157 |
0.23 |
chr16_67618812_67618963 | 0.81 |
CTCF |
CCCTC-binding factor (zinc finger protein) |
22577 |
0.08 |
chr4_39364717_39364868 | 0.81 |
RFC1 |
replication factor C (activator 1) 1, 145kDa |
3177 |
0.21 |
chr10_5339048_5339261 | 0.80 |
AKR1C7P |
aldo-keto reductase family 1, member C7, pseudogene |
8721 |
0.21 |
chr4_143628374_143628525 | 0.80 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
138994 |
0.05 |
chr10_73868827_73869016 | 0.80 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
20131 |
0.19 |
chr1_200121942_200122869 | 0.80 |
ENSG00000221403 |
. |
8443 |
0.27 |
chr12_67972561_67972821 | 0.80 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
69427 |
0.13 |
chr1_169674701_169674897 | 0.80 |
SELL |
selectin L |
6040 |
0.21 |
chr18_43802372_43802526 | 0.80 |
C18orf25 |
chromosome 18 open reading frame 25 |
48449 |
0.14 |
chr8_126941263_126941691 | 0.79 |
ENSG00000206695 |
. |
28282 |
0.26 |
chr12_9921460_9921827 | 0.79 |
CD69 |
CD69 molecule |
8146 |
0.16 |
chr4_110571544_110571753 | 0.79 |
AC004067.5 |
|
41512 |
0.14 |
chr14_61833316_61833710 | 0.79 |
PRKCH |
protein kinase C, eta |
5721 |
0.25 |
chr1_150064790_150064941 | 0.79 |
VPS45 |
vacuolar protein sorting 45 homolog (S. cerevisiae) |
24980 |
0.14 |
chr4_105888170_105888391 | 0.79 |
ENSG00000251906 |
. |
7539 |
0.31 |
chr7_50462451_50462702 | 0.79 |
ENSG00000200815 |
. |
40502 |
0.17 |
chr14_75716729_75717032 | 0.79 |
RP11-293M10.2 |
|
9234 |
0.15 |
chr12_57457472_57457707 | 0.79 |
MYO1A |
myosin IA |
12630 |
0.09 |
chr17_76752517_76752856 | 0.79 |
CYTH1 |
cytohesin 1 |
19714 |
0.17 |
chr1_32377557_32377920 | 0.79 |
AL136115.1 |
HCG2032337; PRO1848; Uncharacterized protein |
1436 |
0.39 |
chr14_36295069_36295332 | 0.78 |
BRMS1L |
breast cancer metastasis-suppressor 1-like |
324 |
0.73 |
chr9_111858912_111859063 | 0.78 |
TMEM245 |
transmembrane protein 245 |
9414 |
0.19 |
chr3_108555721_108555873 | 0.78 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
14178 |
0.25 |
chr7_8166102_8166400 | 0.78 |
AC006042.6 |
|
12596 |
0.21 |
chr5_49713967_49714118 | 0.78 |
EMB |
embigin |
10519 |
0.33 |
chr5_118654433_118654664 | 0.78 |
ENSG00000243333 |
. |
12222 |
0.19 |
chr12_21766880_21767202 | 0.78 |
GYS2 |
glycogen synthase 2 (liver) |
9260 |
0.2 |
chrX_149646217_149646416 | 0.78 |
MAMLD1 |
mastermind-like domain containing 1 |
7036 |
0.24 |
chr16_68030130_68030281 | 0.78 |
DUS2 |
dihydrouridine synthase 2 |
1516 |
0.19 |
chr4_40221424_40221888 | 0.78 |
RHOH |
ras homolog family member H |
19692 |
0.2 |
chr5_56129477_56129628 | 0.77 |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
18151 |
0.15 |
chr3_190230497_190230722 | 0.77 |
IL1RAP |
interleukin 1 receptor accessory protein |
1231 |
0.58 |
chr8_126929763_126929914 | 0.77 |
ENSG00000206695 |
. |
16643 |
0.3 |
chr13_77589131_77589282 | 0.77 |
FBXL3 |
F-box and leucine-rich repeat protein 3 |
12079 |
0.17 |
chr10_11203608_11204588 | 0.77 |
CELF2 |
CUGBP, Elav-like family member 2 |
2895 |
0.29 |
chr1_66742157_66742355 | 0.77 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
18926 |
0.28 |
chr15_22474307_22474699 | 0.77 |
IGHV4OR15-8 |
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
1150 |
0.36 |
chr10_6599818_6600124 | 0.77 |
PRKCQ |
protein kinase C, theta |
22230 |
0.27 |
chr21_34084761_34084912 | 0.77 |
SYNJ1 |
synaptojanin 1 |
14370 |
0.15 |
chr1_147929159_147929310 | 0.77 |
PPIAL4A |
peptidylprolyl isomerase A (cyclophilin A)-like 4A |
26185 |
0.15 |
chr18_60873281_60873558 | 0.76 |
ENSG00000238988 |
. |
11521 |
0.23 |
chr1_111210638_111210814 | 0.76 |
KCNA3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
6929 |
0.19 |
chr1_117352258_117352539 | 0.76 |
CD2 |
CD2 molecule |
55309 |
0.12 |
chr7_6298731_6299016 | 0.76 |
CYTH3 |
cytohesin 3 |
13402 |
0.18 |
chr2_235363626_235363869 | 0.76 |
ARL4C |
ADP-ribosylation factor-like 4C |
41497 |
0.22 |
chr10_26734768_26734919 | 0.76 |
APBB1IP |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
7489 |
0.28 |
chr1_143741628_143741785 | 0.76 |
RP6-206I17.4 |
|
22002 |
0.16 |
chr6_149648126_149648277 | 0.76 |
TAB2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
6013 |
0.22 |
chr2_235369533_235369773 | 0.76 |
ARL4C |
ADP-ribosylation factor-like 4C |
35591 |
0.24 |
chr4_151865552_151865703 | 0.76 |
ENSG00000252451 |
. |
26307 |
0.22 |
chr2_32036582_32036828 | 0.75 |
ENSG00000238448 |
. |
1348 |
0.49 |
chr15_85302679_85303048 | 0.75 |
RP11-7M10.2 |
|
6510 |
0.15 |
chr13_28015570_28015856 | 0.75 |
MTIF3 |
mitochondrial translational initiation factor 3 |
8613 |
0.17 |
chr4_103510077_103510373 | 0.75 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
11204 |
0.22 |
chr20_57753276_57753706 | 0.75 |
ZNF831 |
zinc finger protein 831 |
12584 |
0.25 |
chr10_6586306_6586575 | 0.75 |
PRKCQ |
protein kinase C, theta |
35761 |
0.23 |
chr19_39127082_39127242 | 0.75 |
ACTN4 |
actinin, alpha 4 |
11148 |
0.11 |
chr12_68530648_68530810 | 0.75 |
IFNG |
interferon, gamma |
22798 |
0.24 |
chr6_6611653_6611952 | 0.75 |
LY86-AS1 |
LY86 antisense RNA 1 |
11126 |
0.25 |
chr16_53526439_53526844 | 0.74 |
AKTIP |
AKT interacting protein |
7600 |
0.2 |
chr1_55682788_55682939 | 0.74 |
USP24 |
ubiquitin specific peptidase 24 |
2077 |
0.36 |
chr10_116302582_116302828 | 0.74 |
ABLIM1 |
actin binding LIM protein 1 |
16015 |
0.26 |
chr18_60825707_60826108 | 0.74 |
RP11-299P2.1 |
|
7354 |
0.25 |
chr10_11189349_11189500 | 0.74 |
CELF2 |
CUGBP, Elav-like family member 2 |
17569 |
0.19 |
chr20_50058396_50058617 | 0.74 |
ENSG00000266761 |
. |
11008 |
0.26 |
chrX_135669720_135670141 | 0.74 |
ENSG00000252320 |
. |
4531 |
0.17 |
chr13_42969980_42970150 | 0.74 |
AKAP11 |
A kinase (PRKA) anchor protein 11 |
123776 |
0.06 |
chr17_30683177_30683478 | 0.74 |
ZNF207 |
zinc finger protein 207 |
5400 |
0.15 |
chr14_99706828_99706991 | 0.74 |
AL109767.1 |
|
22376 |
0.2 |
chr10_111771764_111771981 | 0.74 |
ADD3 |
adducin 3 (gamma) |
4150 |
0.23 |
chr5_130706300_130706451 | 0.74 |
CDC42SE2 |
CDC42 small effector 2 |
14924 |
0.29 |
chr8_8731300_8731451 | 0.73 |
MFHAS1 |
malignant fibrous histiocytoma amplified sequence 1 |
19780 |
0.19 |
chr1_91480528_91480679 | 0.73 |
ZNF644 |
zinc finger protein 644 |
6411 |
0.34 |
chr12_9915687_9916017 | 0.73 |
CD69 |
CD69 molecule |
2355 |
0.25 |
chr1_198657444_198657765 | 0.73 |
RP11-553K8.5 |
|
21414 |
0.23 |
chr9_92081450_92081888 | 0.73 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
10801 |
0.24 |
chr14_31597308_31597621 | 0.73 |
HECTD1 |
HECT domain containing E3 ubiquitin protein ligase 1 |
390 |
0.85 |
chr4_6698363_6699122 | 0.73 |
S100P |
S100 calcium binding protein P |
3946 |
0.17 |
chr15_52802125_52802276 | 0.73 |
MYO5A |
myosin VA (heavy chain 12, myoxin) |
18838 |
0.2 |
chr18_57023682_57023833 | 0.73 |
LMAN1 |
lectin, mannose-binding, 1 |
3437 |
0.27 |
chr7_138757554_138757775 | 0.73 |
ZC3HAV1 |
zinc finger CCCH-type, antiviral 1 |
6349 |
0.22 |
chr5_112223439_112223590 | 0.73 |
ZRSR1 |
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 1 |
3799 |
0.15 |
chr2_152494355_152494506 | 0.73 |
NEB |
nebulin |
54297 |
0.17 |
chr3_18477206_18477357 | 0.73 |
SATB1 |
SATB homeobox 1 |
536 |
0.8 |
chr10_7201395_7201546 | 0.73 |
SFMBT2 |
Scm-like with four mbt domains 2 |
249237 |
0.02 |
chr4_13617842_13617993 | 0.73 |
BOD1L1 |
biorientation of chromosomes in cell division 1-like 1 |
11430 |
0.2 |
chr3_186743797_186744281 | 0.73 |
ST6GAL1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
768 |
0.72 |
chr4_153320237_153320432 | 0.72 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
12696 |
0.24 |
chr1_78393596_78393747 | 0.72 |
NEXN |
nexilin (F actin binding protein) |
9858 |
0.18 |
chr2_68606505_68606656 | 0.72 |
AC015969.3 |
|
13864 |
0.17 |
chr2_143904317_143904751 | 0.72 |
ARHGAP15 |
Rho GTPase activating protein 15 |
17651 |
0.23 |
chr5_75745118_75745695 | 0.72 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
45157 |
0.18 |
chr8_82065263_82065697 | 0.72 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
41177 |
0.19 |
chr6_10746876_10747199 | 0.72 |
TMEM14B |
transmembrane protein 14B |
955 |
0.33 |
chr1_78471428_78471772 | 0.72 |
DNAJB4 |
DnaJ (Hsp40) homolog, subfamily B, member 4 |
1062 |
0.38 |
chr2_152279410_152279561 | 0.72 |
RIF1 |
RAP1 interacting factor homolog (yeast) |
12881 |
0.2 |
chr9_135363318_135363556 | 0.72 |
ENSG00000252521 |
. |
66409 |
0.1 |
chr6_130537041_130537253 | 0.72 |
SAMD3 |
sterile alpha motif domain containing 3 |
68 |
0.98 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.7 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.8 | 3.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.8 | 0.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.7 | 2.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.7 | 2.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.7 | 1.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.7 | 5.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.7 | 2.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.7 | 2.0 | GO:0002664 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.6 | 4.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.6 | 1.9 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.6 | 2.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.6 | 1.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.5 | 3.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.5 | 1.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 2.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 2.5 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.5 | 1.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 1.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 2.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 1.9 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.5 | 1.9 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.5 | 1.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 0.9 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.5 | 1.4 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.5 | 1.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 1.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 2.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.4 | 0.4 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.4 | 1.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.4 | 1.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.4 | 2.0 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.4 | 0.4 | GO:0042119 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.4 | 0.4 | GO:0017085 | response to insecticide(GO:0017085) |
0.4 | 1.2 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.4 | 1.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.4 | 29.6 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.4 | 1.2 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.4 | 1.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.4 | 0.4 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.4 | 1.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.4 | 1.5 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 1.1 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.4 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 1.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.4 | 1.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.3 | 1.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 3.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 0.7 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.3 | 1.4 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.3 | 1.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 0.7 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 1.0 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 2.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 2.8 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.3 | 0.3 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.3 | 2.2 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.3 | 1.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.3 | 0.9 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.3 | 0.9 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 0.9 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 1.2 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.6 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.3 | 0.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.3 | 1.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.3 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 0.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 1.5 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.3 | 0.3 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.3 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 1.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 1.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 3.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 0.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 0.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 0.3 | GO:0055078 | cellular sodium ion homeostasis(GO:0006883) sodium ion homeostasis(GO:0055078) |
0.3 | 1.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.3 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.8 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.3 | 0.8 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 0.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 1.8 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.3 | 0.8 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 0.8 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 0.8 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 4.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.3 | 2.5 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.3 | 0.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.8 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 1.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 0.8 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.2 | GO:0043367 | CD4-positive, alpha-beta T cell differentiation(GO:0043367) |
0.2 | 1.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.2 | 0.7 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.2 | 0.7 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.2 | 2.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.7 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 0.2 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.2 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 1.6 | GO:0002837 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.2 | 0.2 | GO:0032623 | interleukin-2 production(GO:0032623) |
0.2 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.4 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.7 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 2.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.7 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 0.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 2.2 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 0.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.2 | 0.4 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 1.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 3.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.2 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.2 | 0.6 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 0.8 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.6 | GO:0035610 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.2 | 1.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 2.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 1.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.2 | 0.6 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.8 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 0.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.8 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.6 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.2 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 1.4 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 0.2 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.2 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 1.0 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.2 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.2 | 1.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 4.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 1.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 0.4 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.2 | 4.6 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 1.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.5 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.5 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 1.1 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.2 | 0.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.2 | 0.5 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.2 | 0.5 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.2 | 0.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.5 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.2 | 0.2 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.2 | 0.3 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 0.2 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 1.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 2.7 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.2 | 0.3 | GO:0033084 | immature T cell proliferation(GO:0033079) immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 0.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.8 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 1.0 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.2 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 2.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 0.3 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.2 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.2 | 0.5 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 0.5 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.2 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 0.5 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.8 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.2 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.2 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.2 | 0.8 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 1.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.8 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 2.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.2 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.2 | 4.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.2 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 1.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.4 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 2.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.6 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.7 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 1.0 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 1.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.6 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 1.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.3 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.6 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.6 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0035304 | regulation of protein dephosphorylation(GO:0035304) |
0.1 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.1 | GO:0045350 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 1.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 1.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.3 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 1.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.8 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.4 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 2.6 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 1.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.3 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 1.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.5 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.1 | 1.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.4 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.4 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.4 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.5 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 2.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.1 | 0.6 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 9.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.4 | GO:0046479 | glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) |
0.1 | 1.6 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.1 | 2.2 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.6 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 1.6 | GO:0043489 | RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
0.1 | 0.4 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.6 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.2 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.4 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 1.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 1.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.6 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.3 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 0.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.3 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.1 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 1.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.6 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.5 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.1 | 0.1 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 3.9 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.3 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.5 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.2 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.1 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) response to histamine(GO:0034776) |
0.1 | 0.2 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.9 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.4 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.2 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.1 | GO:0042991 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.1 | 2.6 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.2 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.1 | GO:0042921 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 1.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 1.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.4 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 0.3 | GO:0075733 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.5 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 2.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 1.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.6 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 1.9 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 0.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.1 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 4.9 | GO:2000134 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 4.8 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.9 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
0.1 | 0.1 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.1 | 0.6 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.6 | GO:0030449 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.1 | 0.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 1.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 1.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.2 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.1 | 0.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.4 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 3.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 1.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.2 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 4.4 | GO:0097194 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.1 | 3.1 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.3 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.7 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 1.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 2.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.5 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.2 | GO:0001704 | formation of primary germ layer(GO:0001704) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.8 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.1 | 0.4 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.2 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.1 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 1.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 1.6 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 | 0.4 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.8 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.1 | 0.8 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 1.1 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 1.0 | GO:0046676 | negative regulation of peptide secretion(GO:0002792) negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
0.1 | 0.2 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.4 | GO:0042267 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.9 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.2 | GO:0072110 | glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) regulation of glomerulus development(GO:0090192) |
0.1 | 0.3 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.1 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.1 | 18.0 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0052552 | modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) |
0.1 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.7 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.8 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.7 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.2 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.4 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 1.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.9 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.2 | GO:1901623 | T cell chemotaxis(GO:0010818) regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) regulation of lymphocyte chemotaxis(GO:1901623) regulation of lymphocyte migration(GO:2000401) positive regulation of lymphocyte migration(GO:2000403) regulation of T cell migration(GO:2000404) positive regulation of T cell migration(GO:2000406) |
0.1 | 0.2 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.1 | 0.4 | GO:0051806 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.1 | 0.2 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.1 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 1.0 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.1 | 2.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.9 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.1 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.7 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.2 | GO:1903902 | positive regulation of viral process(GO:0048524) positive regulation of viral life cycle(GO:1903902) |
0.1 | 0.3 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.3 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.1 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.1 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 1.7 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.1 | 1.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.6 | GO:1901214 | regulation of neuron apoptotic process(GO:0043523) regulation of neuron death(GO:1901214) |
0.1 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.1 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.7 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.1 | 0.2 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 1.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.5 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.1 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.3 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 1.7 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.1 | 0.3 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.3 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.3 | GO:0021561 | facial nerve development(GO:0021561) cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) anatomical structure arrangement(GO:0048532) |
0.1 | 0.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.4 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 3.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.4 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.1 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.4 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 0.4 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.1 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.1 | 2.7 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.1 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 2.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.7 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.1 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.1 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.1 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:0035987 | endodermal cell fate commitment(GO:0001711) endodermal cell differentiation(GO:0035987) |
0.1 | 0.1 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.1 | 0.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 1.0 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0098930 | axonal transport(GO:0098930) |
0.1 | 0.3 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.1 | GO:0010737 | protein kinase A signaling(GO:0010737) regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.1 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.2 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.3 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 1.0 | GO:0046649 | lymphocyte activation(GO:0046649) |
0.1 | 0.1 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.1 | 0.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.7 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.4 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.1 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.9 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.1 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.1 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.1 | 0.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 0.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.5 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.2 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.1 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.5 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 2.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.2 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.8 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 0.4 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 1.0 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.7 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.4 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 1.4 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0072143 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 1.1 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.0 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.2 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 5.1 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.5 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.4 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
0.0 | 0.0 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.0 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.2 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.1 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
0.0 | 0.8 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.4 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.3 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 3.7 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.2 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.8 | GO:0050863 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.2 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 1.6 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.1 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 3.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.0 | GO:0072179 | nephric duct formation(GO:0072179) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 1.2 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.0 | GO:0072177 | mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
0.0 | 0.2 | GO:0097553 | release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
0.0 | 0.8 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.0 | 0.3 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 1.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 0.1 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.0 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.2 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 3.7 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 9.3 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.0 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.0 | 0.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.4 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.0 | 0.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.4 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.1 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.0 | 1.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.1 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.0 | 0.0 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 0.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.4 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 1.0 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:1901222 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.0 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:0048857 | neural nucleus development(GO:0048857) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.4 | GO:0061572 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.0 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.6 | GO:0072655 | protein targeting to mitochondrion(GO:0006626) establishment of protein localization to mitochondrion(GO:0072655) |
0.0 | 0.1 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.4 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.0 | 7.0 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.6 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 2.6 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 1.2 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0021819 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.0 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.0 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.0 | 0.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0035590 | purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.3 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.3 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.1 | GO:0051322 | anaphase(GO:0051322) |
0.0 | 0.0 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.2 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0032274 | gonadotropin secretion(GO:0032274) negative regulation of gonadotropin secretion(GO:0032277) regulation of endocrine process(GO:0044060) |
0.0 | 0.1 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.0 | 0.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 1.6 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.0 | 0.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.2 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.1 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.6 | GO:0070252 | actin-mediated cell contraction(GO:0070252) |
0.0 | 0.1 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 1.2 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) depurination(GO:0045007) |
0.0 | 0.1 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 0.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.0 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.9 | GO:0034660 | ncRNA metabolic process(GO:0034660) |
0.0 | 0.0 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.2 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.0 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.0 | 1.4 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) modification-dependent protein catabolic process(GO:0019941) |
0.0 | 0.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.3 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:2000045 | regulation of cell cycle G1/S phase transition(GO:1902806) regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.0 | 0.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.0 | GO:1903523 | negative regulation of heart contraction(GO:0045822) negative regulation of blood circulation(GO:1903523) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.0 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.0 | GO:1902115 | regulation of sarcomere organization(GO:0060297) regulation of organelle assembly(GO:1902115) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.2 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.0 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.0 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.0 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.2 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 5.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0036315 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.0 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0015800 | acidic amino acid transport(GO:0015800) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 6.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 2.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.7 | 2.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.6 | 3.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 1.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 1.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 1.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 1.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 1.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 4.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 0.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 3.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 1.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 1.4 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 1.1 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 3.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 2.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 1.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 4.1 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.2 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 1.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.3 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 4.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 0.6 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 1.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 1.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.4 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.6 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 1.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 2.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 6.4 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 1.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 1.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 1.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 1.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 2.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.6 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.9 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 1.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.6 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 4.4 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 1.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.6 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 1.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 1.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 1.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.7 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.4 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 1.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 6.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 2.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.7 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 5.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.7 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.4 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.7 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 11.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 6.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 1.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.1 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.1 | 1.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.3 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.6 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.5 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.3 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 12.5 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 3.6 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.2 | GO:0016529 | sarcoplasm(GO:0016528) sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 4.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.3 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 3.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 3.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.4 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 5.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 0.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 1.1 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.3 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.3 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 6.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.5 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 2.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.0 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 7.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.3 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.1 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 1.3 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 1.4 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.5 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 0.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.9 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.7 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 3.9 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.2 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.1 | 3.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 3.4 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 1.4 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.5 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 1.4 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.3 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.1 | GO:0000803 | sex chromosome(GO:0000803) |
0.0 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 4.9 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 25.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.2 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 1.3 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.0 | 0.6 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 3.2 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.5 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 10.6 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 1.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.0 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.0 | 0.9 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 6.4 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 53.4 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 1.8 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.3 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.7 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 7.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 2.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 91.4 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0031967 | organelle envelope(GO:0031967) |
0.0 | 0.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 1.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 11.5 | GO:0044432 | endoplasmic reticulum part(GO:0044432) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 2.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 8.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 66.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.0 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.0 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.7 | 2.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 2.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.7 | 2.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.6 | 1.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.6 | 1.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.6 | 1.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.6 | 8.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 2.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.5 | 1.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.5 | 1.4 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.4 | 2.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 1.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.4 | 1.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.4 | 2.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 2.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 8.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 6.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.4 | 1.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 1.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 1.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 3.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.3 | 4.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 3.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 1.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 3.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 1.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 3.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 0.8 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 0.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 0.8 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 0.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 1.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 6.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 4.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 0.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.5 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 1.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.9 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 3.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 2.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 2.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 1.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 1.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 10.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 7.2 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 1.0 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 1.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 2.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 2.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.9 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.2 | 5.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 1.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 3.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 9.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 1.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 1.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 0.5 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 1.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.2 | 0.5 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 0.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 1.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 3.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 1.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 2.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.0 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 4.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 1.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 4.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 3.3 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 1.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.1 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 1.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.4 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 4.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.0 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 3.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 1.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 2.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 1.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 3.1 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 5.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.6 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 1.5 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 1.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 1.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 2.0 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 2.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 1.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 3.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.6 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
0.1 | 0.5 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 1.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.5 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 1.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.4 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 1.2 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 0.3 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 2.7 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.8 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 2.2 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 2.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.3 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.8 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 2.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.4 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 1.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 1.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.6 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 1.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.2 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 14.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 3.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.1 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.1 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 5.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 1.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.3 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.5 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 2.1 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.1 | 0.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.3 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 0.1 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 4.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.3 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 2.9 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 1.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.2 | GO:0004396 | hexokinase activity(GO:0004396) |
0.1 | 0.5 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 1.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 1.1 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 30.6 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 2.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.3 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 6.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.1 | GO:0044620 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.3 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.2 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.5 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.1 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 2.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.4 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.6 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 8.3 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 3.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 12.1 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 1.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.9 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.0 | 0.6 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.3 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 1.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.7 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.0 | 2.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 48.8 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 1.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.2 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 2.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.6 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.4 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 0.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 3.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.0 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.2 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.4 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.0 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.0 | 3.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 1.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 1.4 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.8 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.3 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 1.2 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 1.3 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.1 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.0 | 0.8 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 4.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.0 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 33.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 4.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 8.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 8.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 1.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 1.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 10.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 2.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 4.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 3.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 3.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 0.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 4.9 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 2.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 9.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 5.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 6.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 2.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 3.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 1.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 1.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 1.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 4.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 3.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 0.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 4.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 3.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 5.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 3.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 3.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 4.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 2.9 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 1.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 2.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 8.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.6 | 1.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 8.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.6 | 4.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.6 | 1.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.5 | 7.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 7.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 5.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 4.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 9.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 0.7 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 7.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 2.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 2.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 6.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 7.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 6.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 3.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 4.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 2.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 3.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 1.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 6.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 2.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 2.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 2.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 1.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 9.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 4.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 4.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 1.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 5.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 1.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 0.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 0.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 2.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 6.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 4.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 2.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 1.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 2.0 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 6.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 3.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 7.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 6.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 10.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.5 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.1 | 1.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.3 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 1.7 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 5.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.0 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 0.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 2.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 7.0 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 2.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 1.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 1.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.0 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 3.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 1.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 4.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 7.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.0 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 4.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |